News
Emily Bodnar, an analyst at H.C. Wainwright, raised her price target for Purple Biotech Ltd. (NASDAQ:PPBT) from $33 to $34 ...
Amid ongoing uncertainty around funding for the NIH and what it could mean for U.S. innovation, a top Merck executive ...
This week ended up as a pretty active one for large startup financings. AI and biotech were the biggest areas for funding, ...
Ailsa Craig and Marek Poszepczynski, portfolio managers at the International Biotechnology Trust, tell MoneyWeek where they’d ...
The best fertilizer for tomatoes allows your plants to grow while providing nutrients. See shopping tips and recommendations ...
We assign Veeva’s commercial solutions a wide moat based on customer switching costs. Veeva CRM is Veeva’s cloud-based customer relationship management platform. It markets to pharmaceutical and ...
Orchestra BioMed holds two best-in-class medical device therapies targeting large markets. Find out why OBIO stock is a Buy.
Biotechnology is often hailed as the future of cosmetic formulations. Here,, Director and Cosmetic Chemist at the Institute ...
Eli Lilly acquires SiteOne Therapeutics for up to $1 billion, signaling potential uptick in Big Pharma deals and focus on ...
In partnership with the Silicon Valley Business Journal, we'll honor the Bay Area's top companies recognized as the Best ...
Big Biotech Biogen is venturing into the city, paying $16 million in cash to partner up with an RNAi company to build ...
Ankyra Therapeutics is a biotech developing anchored immunotherapies aimed at enhancing the therapeutic window of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results